SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882104-16-000206
Filing Date
2016-11-03
Accepted
2016-11-03 17:23:25
Documents
90
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pdli-2016093010qdoc.htm 10-Q 1677624
2 RATIO OF EARNINGS TO FIXED CHARGES pdli-2016093010qex121.htm EX-12.1 59938
3 CERTIFICATION pdli-2016093010qex311.htm EX-31.1 11001
4 CERTIFICATION pdli-2016093010qex312.htm EX-31.2 11264
5 CERTIFICATION pdli-2016093010qex321.htm EX-32.1 14289
12 pdl-logoa05a01a01a01a05.jpg GRAPHIC 59351
  Complete submission text file 0000882104-16-000206.txt   11406359

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pdli-20160930.xml EX-101.INS 2700764
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20160930.xsd EX-101.SCH 94321
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20160930_cal.xml EX-101.CAL 114401
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20160930_def.xml EX-101.DEF 422057
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20160930_lab.xml EX-101.LAB 897622
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20160930_pre.xml EX-101.PRE 587786
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 161972846
SIC: 2836 Biological Products, (No Diagnostic Substances)